Synthetic viability: FANCM loss enhances the fitness of BRCA2 mutant cells
In this issue of Molecular Cell, Dossin et al. show that FANCM loss has opposing effects in BRCA1-versus BRCA2-deficient cells, revealing distinct roles for FANCM and potential therapeutic implications for treating BRCA1- and BRCA2-mutant cancers.